Crescent Capital BDC, Inc.
Crescent Capital BDC, Inc. Fundamental Analysis
Crescent Capital BDC, Inc. (FCRX) shows moderate financial fundamentals with a PE ratio of 25.92, profit margin of 20.83%, and ROE of 4.96%. The company generates $0.2B in annual revenue with strong year-over-year growth of 12.83%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 47.4/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze FCRX's fundamental strength across five key dimensions:
Efficiency Score
WeakFCRX struggles to generate sufficient returns from assets.
Valuation Score
ModerateFCRX shows balanced valuation metrics.
Growth Score
ModerateFCRX shows steady but slowing expansion.
Financial Health Score
ModerateFCRX shows balanced financial health with some risks.
Profitability Score
ModerateFCRX maintains healthy but balanced margins.
Key Financial Metrics
Is FCRX Expensive or Cheap?
P/E Ratio
FCRX trades at 25.92 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, FCRX's PEG of -1.41 indicates potential undervaluation.
Price to Book
The market values Crescent Capital BDC, Inc. at 1.31 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 0.00 times EBITDA. This is generally considered low.
How Well Does FCRX Make Money?
Net Profit Margin
For every $100 in sales, Crescent Capital BDC, Inc. keeps $20.83 as profit after all expenses.
Operating Margin
Core operations generate 75.76 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $4.96 in profit for every $100 of shareholder equity.
ROA
Crescent Capital BDC, Inc. generates $2.21 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Crescent Capital BDC, Inc. generates limited operating cash flow of $14.04M, signaling weaker underlying cash strength.
Free Cash Flow
Crescent Capital BDC, Inc. produces free cash flow of $14.04M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $0.38 in free cash annually.
FCF Yield
FCRX converts 1.50% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
25.92
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-1.41
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.31
vs 25 benchmark
P/S Ratio
Price to sales ratio
5.40
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
1.23
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.26
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.05
vs 25 benchmark
ROA
Return on assets percentage
0.02
vs 25 benchmark
ROCE
Return on capital employed
0.08
vs 25 benchmark
How FCRX Stacks Against Its Sector Peers
| Metric | FCRX Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 25.92 | 18.86 | Worse (Expensive) |
| ROE | 4.96% | 847.00% | Weak |
| Net Margin | 20.83% | 4202.00% | Weak |
| Debt/Equity | 1.23 | 0.91 | Weak (High Leverage) |
| Current Ratio | 1.26 | 667.17 | Neutral |
| ROA | 2.21% | -21543.00% (disorted) | Weak |
FCRX outperforms its industry in 0 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Crescent Capital BDC, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
485.03%
Industry Style: Value, Dividend, Cyclical
High GrowthEPS CAGR
90.90%
Industry Style: Value, Dividend, Cyclical
High GrowthFCF CAGR
122.02%
Industry Style: Value, Dividend, Cyclical
High Growth